Mood Disorders: Depression & Bipolar – MRCP Part 1
- Crack Medicine

- 1 day ago
- 3 min read
TL;DR
Mood disorders are a high-yield psychiatry topic in MRCP Part 1, most commonly testing diagnostic criteria, differentiation between unipolar depression and bipolar disorder, and first-line pharmacology. Examiners favour subtle distinctions such as mania versus hypomania, antidepressant-induced switching, and lithium safety. This article provides an exam-focused framework, a worked MCQ, common traps, and a practical revision checklist.
Why mood disorders matter in MRCP Part 1
Psychiatry contributes a reliable proportion of questions in MRCP Part 1, and mood disorders form one of its most predictable areas. Questions are rarely vague: they test whether candidates can apply definitions, durations, exclusions, and drug safety rather than broad descriptions.
Most stems are clinically realistic and short. A single missed clue—such as a past hypomanic episode or renal impairment in a patient on lithium—often determines the correct answer. For syllabus context, review the official structure on the MRCP(UK) website and the Crack Medicine hub:
MRCP Part 1 overview: https://www.crackmedicine.com/mrcp-part-1/
Scope of examinable content
For MRCP Part 1, mood disorders are assessed through:
Core diagnostic criteria (ICD-10 / DSM-5 principles)
Differentiation of depressive episodes, mania, and hypomania
Bipolar subtypes and course patterns
Antidepressants and mood stabilisers (indications, risks, adverse effects)
Organic and drug-induced mood disorders
Suicide risk and emergency management principles
Psychotherapy models and detailed rating scales are not examined.
High-yield outline: what to know cold
1. Major depressive disorder (unipolar depression)
At least 2 weeks of persistent low mood and/or anhedonia
Associated symptoms: sleep disturbance, appetite change, fatigue, poor concentration, guilt, suicidal ideation
Always exclude past mania or hypomania before diagnosing unipolar depression
2. Bipolar affective disorder
Bipolar I: at least one manic episode (depression may or may not occur)
Bipolar II: hypomanic episodes plus major depressive episodes, no full mania
3. Mania vs hypomania (classic exam discriminator)
Mania:
≥7 days (or any duration if hospitalisation required)
Marked functional impairment
Psychotic features may occur
Hypomania:
≥4 days
No psychosis
No severe social or occupational dysfunction
4. Antidepressants
SSRIs are first-line for moderate–severe unipolar depression
Can precipitate mania or rapid cycling in bipolar disorder
Common adverse effects: GI upset, sexual dysfunction, QT prolongation (specific agents), hyponatraemia (elderly)
5. Mood stabilisers
Lithium:
Gold standard for relapse prevention
Narrow therapeutic index
Adverse effects: tremor, hypothyroidism, nephrogenic diabetes insipidus
Valproate: effective but teratogenic
Lamotrigine: bipolar depression and maintenance (risk of Stevens–Johnson syndrome)
6. Rapid cycling bipolar disorder
≥4 mood episodes in 12 months
Associated with poorer prognosis
Antidepressants may worsen cycling
7. Psychotic depression
Mood-congruent delusions or hallucinations
Requires antidepressant plus antipsychotic or ECT
8. Organic and secondary causes
Hypothyroidism, Parkinson’s disease, stroke, corticosteroids
Late-onset depression is organic until proven otherwise
Most tested subtopics at a glance
Subtopic | What MRCP Part 1 tests |
Diagnostic thresholds | Duration, severity, exclusion of mania |
Mania vs hypomania | Functional impairment, psychosis |
Lithium | Side effects, interactions, monitoring |
Antidepressants | Switching to mania, serotonin syndrome |
Special groups | Pregnancy, renal disease, elderly |

Mini-case (MCQ style)
Question A 29-year-old woman presents with 5 days of elevated mood, reduced need for sleep, increased talkativeness, and increased goal-directed activity. She continues to attend work and reports feeling unusually productive. There is no psychosis. She has had two previous depressive episodes.
What is the most likely diagnosis?
A. ManiaB. HypomaniaC. CyclothymiaD. Schizoaffective disorderE. Major depressive disorder
Correct answer: B. Hypomania
Explanation The episode lasts ≥4 days, lacks psychotic features, and does not cause marked functional impairment. A history of depressive episodes plus hypomania supports bipolar II disorder. Mania would require severe impairment, hospitalisation, or psychosis.
Five common exam traps
Diagnosing unipolar depression without excluding past hypomania
Misclassifying hypomania as mania due to symptom intensity alone
Forgetting lithium contraindications (renal disease, dehydration, ACE inhibitors)
Ignoring medical causes of new-onset depression in older adults
Assuming antidepressants are always safe in bipolar disorder
Practical study-tip checklist
Memorise time thresholds (2 weeks, 4 days, 7 days)
Create a one-page mania vs hypomania comparison
Pair each drug with one major adverse effect
Practise psychiatry questions regularly using a real question bank:https://www.crackmedicine.com/qbank/
Use short, spaced reviews rather than long psychiatry-only sessions
For structured teaching, see psychiatry-focused sessions here:https://www.crackmedicine.com/lectures/
FAQs
Is bipolar disorder commonly tested in MRCP Part 1?
Yes. Bipolar disorder is frequently examined, particularly the distinction between mania and hypomania and medication-related risks.
How much pharmacology do I need to know?
Focus on indications, major adverse effects, and contraindications rather than detailed dosing.
Can SSRIs cause mania in exam questions?
Yes. Antidepressant-induced switching is a classic MRCP Part 1 theme.
Is ECT within the MRCP Part 1 syllabus?
Yes. Indications and common adverse effects are examinable, not procedural details.
Ready to start?
Consolidate this topic by attempting psychiatry blocks from the Practise psychiatry MCQs section and revisiting the MRCP Part 1 overview hub to track syllabus coverage.
Sources
MRCP(UK) Part 1 Examination Syllabus: https://www.mrcpuk.org/mrcpuk-examinations/part-1
NICE Guideline CG90: Depression in adults: https://www.nice.org.uk/guidance/cg90
NICE Guideline CG185: Bipolar disorder: https://www.nice.org.uk/guidance/cg185



Comments